BioAmber Inc.
DelistedCIK 1534287fmd_01X6EDZQAGWEDXD24FPK9H5PG1Manufacturing · Industrial Organic ChemicalsTemplate: Standard
Coverage: Jul 01, 2009 to Dec 31, 2017, 27 periods
Latest annual · FY2017
Millions- Total revenues
- 15
- Gross profit
- (0)
- Operating income
- (110)
- Net income
- (98)
Latest quarter · Q4 FY2017
Millions- Total revenues
- 5
- Operating income
- (84)
- Net income
- (84)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2014 to FY2017
- +113.2%
- Revenue, 5 yearsFY2012 to FY2017
- +45.5%
- Net income, 5 yearsFY2012 to FY2017
- n/m
BioAmber Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Revenue | $14.9 million | $8.3 million | +80.6% | 10-K 2018-03-30 · proof |
| Operating income | -$110 million | -$29.6 million | 10-K 2018-03-30 · proof | |
| Net income | -$98.2 million | -$22.5 million | 10-K 2018-03-30 · proof | |
| Cash from operating activities | -$29.8 million | -$37.6 million | 10-K 2018-03-30 · proof | |
| Total assets | $69.5 million | $161.3 million | -56.9% | 10-K 2018-03-30 · proof |
| Total liabilities | $47.7 million | $75.3 million | -36.7% | 10-K 2018-03-30 · proof |
| Cash and cash equivalents | $4.6 million | $16.2 million | -71.3% | 10-K 2018-03-30 · proof |
| Total debt | $37.6 million | $52.3 million | -28.1% | 10-K 2018-03-30 · proof |
- What was BioAmber Inc.'s revenue in fiscal 2017?
- BioAmber Inc. reported revenue of $14.9 million for fiscal 2017 (the year ended Dec 31, 2017), against $8.3 million the year before (+80.6%). Source: the 10-K filed with the SEC on Mar 30, 2018. SEC
- What was BioAmber Inc.'s operating income in fiscal 2017?
- BioAmber Inc. reported operating income of -$110 million for fiscal 2017 (the year ended Dec 31, 2017), against -$29.6 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2018. SEC
- What was BioAmber Inc.'s net income in fiscal 2017?
- BioAmber Inc. reported net income of -$98.2 million for fiscal 2017 (the year ended Dec 31, 2017), against -$22.5 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2018. SEC
- What was BioAmber Inc.'s cash from operating activities in fiscal 2017?
- BioAmber Inc. reported cash from operating activities of -$29.8 million for fiscal 2017 (the year ended Dec 31, 2017), against -$37.6 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2018. SEC
- What are BioAmber Inc.'s total assets?
- As of Dec 31, 2017, BioAmber Inc. reported total assets of $69.5 million, against $161.3 million a year earlier (-56.9%). Source: the 10-K filed with the SEC on Mar 30, 2018. SEC
- What are BioAmber Inc.'s total liabilities?
- As of Dec 31, 2017, BioAmber Inc. reported total liabilities of $47.7 million, against $75.3 million a year earlier (-36.7%). Source: the 10-K filed with the SEC on Mar 30, 2018. SEC
- What are BioAmber Inc.'s cash and cash equivalents?
- As of Dec 31, 2017, BioAmber Inc. reported cash and cash equivalents of $4.6 million, against $16.2 million a year earlier (-71.3%). Source: the 10-K filed with the SEC on Mar 30, 2018. SEC
- What is BioAmber Inc.'s total debt?
- As of Dec 31, 2017, BioAmber Inc. reported total debt of $37.6 million, against $52.3 million a year earlier (-28.1%). Source: the 10-K filed with the SEC on Mar 30, 2018. SEC
Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1534287&period_type=annual&limit=5"Information only, not investment advice.